Glaxosmithkline, INC
Pharmaceutical and Healthcare Company
Based in DC
AI Overview
With $2.0M in lobbying spend across 32 quarterly filings, Glaxosmithkline, INC is a significant lobbying presence. They deploy 11 individual lobbyists Their lobbying covers 1 issue area. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $320K |
| 2019 | $320K |
| 2020 | $270K |
| 2021 | $240K |
| 2022 | $240K |
| 2023 | $240K |
| 2024 | $180K |
| 2025 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Strategic guidance and counsel on health care related issues to include: healthcare reform, HIV/AIDS, bio-defense, Medicare/Medicaid
Strategic guidance and advocacy on health care related issues to include: healthcare reform, HIV/AIDS, bio-defense, Medicare/Medicaid
Strategic guidance and advocacy on health care related issues to include: healthcare reform, HIV/AIDS, bio-defense, Medicare/Medicaid and FDA
Related Analysis
Related Investigations
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.